FDA Inspection 1211251 — Dr. Morag M. Griffin
The FDA completed an inspection of Dr. Morag M. Griffin on Jul 14, 2023 in Leeds. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 14, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Leeds (United Kingdom)
Additional details
Clinical Investigator (CI)